Deferiere Raphael has filed 3 insider transactions across 1 company since June 2025.
Most recent transaction: a grant/award of 11000 shares of Centessa Pharmaceuticals plc ($CNTA) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Centessa Pharmaceuticals plc | $CNTA | Deferiere Raphael | Chief Accounting Officer | A | Ordinary Shares | 11000 | $0.00 | 11,000.0000 | 134,447,836 | 9999.99% | 0.01% |
| Feb. 2, 2026 | Centessa Pharmaceuticals plc | $CNTA | Deferiere Raphael | Chief Accounting Officer | A | Share Option (right to buy) | 42000 | $0.00 | 42,000.0000 | 134,447,836 | 9999.99% | 0.03% |
| June 2, 2025 | Centessa Pharmaceuticals plc | $CNTA | Deferiere Raphael | Chief Accounting Officer | A | Share Option (right to buy) | 165000 | $0.00 | 165,000.0000 | 133,184,349 | 9999.99% | 0.12% |